We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 65% below its sector, cheaper than its peers on earnings.
Mercator Medical S.A., operating with its subsidiaries, is a key player in the manufacturing and international supply of essential disposable medical provisions. Their primary offerings encompass a broad spectrum of medical gloves, including surgical, protective, sterile examination, and household types, alongside various wound dressings and products made from non-woven fabrics. The company's extensive inventory also features a comprehensive range of single-use apparel like caps, face masks, surgical gowns, shoe covers, staff shirts, sleeve protectors, and patient gowns. Furthermore, Mercator Medical provides specialized surgical items such as drape sheets, unique sterile drapes with non-adhesive openings, complete surgical kits, and a variety of accessories like apparatus and table covers, limb protectors, camera covers, adhesive instrument pockets, and self-adhesive nonwoven tapes. These products are sold under a strong collection of brands, including nitrylex, opero, MERCATOR, Ansell, dermagel, santex, comfort, vinylex, iNtouch, ambulance, and ideal. Their customer base is diverse, spanning medical clients such as healthcare facilities, industrial settings requiring medical supplies, retail chains, and pharmaceutical wholesalers, as well as a wide array of other sectors including beauty, hospitality (hotels, restaurants, catering), cleaning services, agri-food, automotive, home and garden, education, and general retail. Established in 1989, Mercator Medical S.A. is based in Kraków, Poland, and functions as a subsidiary of Anabaza RAIF V.C.I.C. Ltd.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save MRC.WA and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.